A case series of serious and unexpected adverse drug reactions under treatment with cariprazine

A case series of serious and unexpected adverse drug reactions under treatment with cariprazine

Abstract Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.

Bibliographic Details
Main Authors: Johannes Heck, Johanna Seifert, Dirk O. Stichtenoth, Christoph Schroeder, Adrian Groh, Gregor R. Szycik, Detlef Degner, Ivana Adamovic, Michael Schneider, Catherine Glocker, Eckart Rüther, Stefan Bleich, Renate Grohmann, Sermin Toto
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Clinical Case Reports
Subjects:
adverse drug reactions
cariprazine
dopamine supersensitivity psychosis
drug safety
hyperprolactinemia
Online Access:https://doi.org/10.1002/ccr3.4084

Similar Items

Similar Items